Piperonyl butoxide
Rid Mousse (piperonyl butoxide) is a small molecule pharmaceutical. Piperonyl butoxide was first approved as Rid mousse on 2000-03-07. It is used to treat lice infestations and scabies in the USA.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Piperonyl butoxide
+
Pyrethrins
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
RID MOUSSE | Bayer | N-021043 DISCN | 2000-03-07 | 1 products |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
sunmark lice solution kit | OTC monograph final | 2022-11-16 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | PIPERONYL BUTOXIDE |
INN | — |
Description | Piperonyl butoxide is a member of benzodioxoles. It has a role as a pesticide synergist. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CCCCOCCOCCOCc1cc2c(cc1CCC)OCO2 |
Identifiers
PDB | — |
CAS-ID | 51-03-6 |
RxCUI | 8345 |
ChEMBL ID | CHEMBL1201131 |
ChEBI ID | 32687 |
PubChem CID | 5794 |
DrugBank | DB09350 |
UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,874 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
40 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more